Performed in a single session without any surgical incisions or scarring, the treatment utilizes an advanced fusion-guided system that combines magnetic resonance imaging (MRI) with precise prostate ...

Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

Sunshine Coast University Hospital to see $2.3 million service expansion. In a Southern Hemisphere first, the service now offers a new Cone Beam CT ...

The Radioligand Therapy Market is projected to reach US$13 billion by 2030, growing at an estimated rate of 5%. Key drivers of this growth include the rising incidence of cancers such as prostate ...

Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it has received Category III Current ...

LOS CABOS, BAJA CALIFORNIA SUR, Mexico, March 10, 2026 /PRNewswire/ -- Longevity Medical Institute(R) today announced the launch of its AI-enhanced full-body MRI program, the first of its kind in Los ...

Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.

Nuclear fusion group SHINE Technologies said it has raised $240 million in equity funding to advance the company's commercial ...

LOS CABOS, BAJA CALIFORNIA SUR, Mexico, March 10, 2026 /PRNewswire/ -- Longevity Medical Institute® today announced the launch of its AI-enhanced ...

Telix Pharmaceuticals focuses on radiopharmaceuticals for the diagnosis and treatment of cancer.

SHINE Technologies, a nuclear fusion company, today announced it has raised $240 million in equity funding, and appointed Dr. Patrick Soon-Shiong, M.D., Executive Chairman of ImmunityBio and founder ...

CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating ...